Ostap Dovirak
Papers
4
Total Citations
40
H-Index
2
About
Ostap Dovirak is a urologic surgeon and researcher whose work centers on improving patient outcomes in prostate cancer and minimally invasive urologic surgery. His key contributions lie in two areas: refining how we measure quality of life after prostate cancer treatment, and advancing the safety and technique of robotic urologic procedures. His most cited work, a 2016 study on the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP), demonstrated the feasibility of integrating a short, patient-reported quality-of-life questionnaire into routine clinical care following robot-assisted radical prostatectomy—a practical tool that has since been used to better capture patient experiences and guide postoperative management. With 30 citations, this paper underscores his commitment to patient-centered outcomes. Dovirak has also investigated perioperative safety, notably evaluating the risks of continuing antiplatelet therapy (aspirin and clopidogrel) during robotic partial nephrectomy, and has pioneered surgical techniques, including robot-assisted ureteroileal reimplantation for post-cystectomy anastomotic strictures, presented at the Journal of Urology. His work bridges clinical innovation and patient safety, making him a notable figure in the evolution of robotic urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2Aspirin and clopidogrel during robotic partial nephrectomy, is it safe?6 citations · 2015
- 3
- 4